Shares fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant’s ...

Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to ...

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Novo Nordisk shares fell Tuesday after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant's blockbuster shots. Shares fell as much as 9.8% in ...

Novo Nordisk, the Danish maker of Ozempic and Wegovy ... moving ahead in the race between drugmakers to offer a weight loss pill. The move comes less than a week after Novo’s largest rival ...

Novo Nordisk NOVO.B2.68%increase; green up pointing triangle shares fell Tuesday after Eli Lilly LLY-0.82%decrease; red down pointing triangle announced results of a new pill that could rival the ...